A multicenter effort was begun in 1994 to characterize the pathophysiology of dengue using a study design that minimized patient selection bias by offering enrollment to all children with undifferentiated fever for õ72 h. In the first year, 189 children were enrolled (age range, 8 months to 14 years). Thirty-two percent of these children had dengue infections (60 volunteers). The percentage of children with a secondary dengue infection was 93%, with only 4 (7%) having a primary dengue infection. The virus isolation rate from the plasma of children with dengue was 98%. Viremia correlated highly with temperature. All four dengue virus serotypes were isolated at both study sites. This study demonstrates that all four serotypes of dengue virus can cause dengue hemorrhagic fever, that all dengue patients as defined by serology experience viremia during the febrile phase, and that as fever subsides, so does viremia.
Dengue is a major cause of morbidity in tropical and subtropavoidance. Dengue is an emerging disease throughout tropical and subtropical regions as the territory of its principal vector, ical areas. It is estimated that ú250,000 cases of severe dengue infections, called dengue hemorrhagic fever (DHF), and at least A. aegypti, expands to include Asia, Africa, Central America, South America, and the Pacific [9] . 100 million cases of uncomplicated dengue fever (DF) occur annually [1] . Dengue viruses consist of four serotypes and are Preexisting dengue cross-reactive antibodies and T cells are central to the immune enhancement theory of dengue pathogentransmitted by mosquitoes, particularly Aedes aegypti [2] . DF in adults is typically a flu-like illness characterized by fever, esis, which attempts to explain why sequential or secondary dengue infections are more likely to result in severe disease headache, eye pain, myalgia, arthralgia, and rash [3, 4] . Most dengue infections in children are mild or asymptomatic but than first or primary infections. According to this hypothesis, cross-reactive nonneutralizing antibodies from a previous hetmay present as undifferentiated fever, classic DF, or DHF [5, 6] . DHF includes plasma leakage that may lead to shock, and erologous dengue infection facilitate virus entry into Fc receptor -bearing cells such as monocyte/macrophages. This indefects in hemostasis including thrombocytopenia that may result in hemorrhage. Mortality rates for hospitalized DHF pacrease in the number of antigen-presenting cells activates precursor cross-reactive memory T cells, which are present in tients in dengue-endemic areas range from õ1% to 40% [7] . There is no treatment other than careful fluid management high numbers as a result of previous heterologous infection. This leads to the release of chemical mediators that cause [8] . No preventive measures are available beyond mosquito plasma leakage and results in increased disease severity [10, 11] . The purpose of this study was to characterize the early viro-hospital until 1 day following defervescence. Data were collected all patients during the first 3 study days and then with the remaining specimens from patients whose plasma samples contained virus and treatment was provided according to standard guidelines. Blood samples were obtained daily up to a maximum of 5 consecduring the first 3 days. In brief, viremia was assessed by injecting 20 live mosquitoes with 0.34 mL of undiluted patient sera. After utive collections, and a follow-up specimen was obtained Ç8 days after enrollment. A right lateral decubitus chest radiograph 14 days, Ç15 of the surviving mosquitoes were tested for flavivirus antigen by IFA of the head [16] . The number of positive tests was obtained on the day after defervescence. Children who had antibody responses diagnostic of an acute dengue virus infection over the number of mosquitoes tested was recorded. Virus-positive mosquitoes were used to infect C6/36 cell cultures for identificahad additional blood samples collected at 6 months and 1 year after enrollment.
tion of virus type using a panel of monoclonal antibodies against dengue and Japanese encephalitis virus (JEV) in an EIA [17] . Definitions. Study day 1 is the day on which a child was enrolled in the study and the first blood sample was obtained.
Antibody responses. IgM and IgG to dengue and JEV were measured in all specimens by antibody capture EIA [18] . For single Fever day 0 is the day of defervescence, that is, the day that the temperature fell below 38ЊC without further significant temperature specimens, 40 U of IgM to dengue (with dengue IgM greater than JEV IgM) was considered evidence of a dengue infection (30 U elevation. Days prior to fever day 0 are designated fever day 01 (1 day before defervescence), fever day 02, etc. The day after if from paired sera with õ15 U of antibody in the acute specimen).
A dengue IgM-to-IgG ratio §1.8:1 defined a primary dengue infecdefervescence is fever day 1. Assessment of disease severity followed the World Health Organization grading system [13] . Chiltion. A ratio õ1.8:1 defined a secondary dengue infection. With serial specimens, a 2-fold increase in IgG to dengue with an absodren with a confirmed diagnosis of dengue based on viremia or antibody responses (or both) without evidence of plasma leakage lute value of §100 U indicated a secondary infection in the absence of IgM to dengue of §40 U. were considered to have DF; those with a fall in platelets and plasma leakage manifested by either a 20% increase in hematocrit, Hemagglutination-inhibition (HAI) antibody against dengue virus types 1-4 and JEV were measured in all specimens [19] . A a pleural effusion, or ascites without shock were diagnosed as having DHF grade 1 (DHF-1, no spontaneous hemorrhage) or 4-fold increase was considered positive for acute flavivirus infection. The infection was diagnosed as primary if titers §1 week DHF-2 (spontaneous hemorrhage). Dengue patients experiencing peripheral vascular collapse with a pulse pressure of £20 mm Hg after onset of illness were £1:1280 or as secondary if antibody titers were ú1:1280 [13] . or clinical signs of shock (or both) were considered to have DHF-3; those with undetectable blood pressure were diagnosed as hav-A serologic diagnosis was assigned to each patient on the basis of EIA and HAI results. Patients in whom the serologic diagnosis ing DHF-4. Other febrile illnesses (OFI) were defined as cases with no antibody evidence of dengue infection, no isolation of was suggestive of a recent (rather than acute) dengue infection (falling IgM level, fixed HAI titer of §2560, or both) or for dengue virus, and no obvious bacterial, rickettsial, or protozoal etiology. OFI was a diagnosis of exclusion; most illnesses were whom no convalescent specimen was available and no virus was isolated were diagnosed as ''unknown'' and were excluded from self-limited and presumed to be viral infections other than dengue. 
Virus isolation. A dengue virus was isolated from the
Data and specimen collection. Study participants were examplasma of 59 of the 60 dengue patients (table 2). The remaining ined daily by a study physician, and a case report form was compatient (KPP94-029) had clear serologic evidence for an acute pleted. Daily blood specimens were collected into EDTA anticoagsecondary dengue infection; he defervesced within 3 h of veniulant and maintained on wet ice until received in the processing puncture for the first blood sample, which had elevated antilaboratory. There, while at 4ЊC throughout, samples were centribody levels (dengue IgM Å 95 U, HAI Å 1:1280). Of the 129 fuged at 300 g for 10 min, the resulting platelet-rich plasma was children who did not have serologic test results diagnostic of recentrifuged at 800 g, and the platelet-poor plasma supernatant acute dengue infection, none had a dengue virus isolated.
was frozen at 070ЊC until assays were performed.
Virus identification. The serotypes of the 59 dengue viruses
Virus isolation. Virus isolation in Toxorhynchites splendens mosquitoes [14, 15] virus type 4 isolated in the single blood specimen collected 2 were isolated in at least 5 of the 8 study months and type 3 days before defervescence; no convalescent blood sample was was isolated from August through November. In Kamphaeng available for antibody analysis. Only 4 of the 59 children with Phet, types 2 and 4 were isolated from April through July. diagnostic antibody responses had primary infections (e.g., Dengue virus type 3 was isolated in May and June, and the figure 2A), and the rest had secondary infections (e.g., figure single type 1 virus was isolated in September. There were no 2B). All 4 of the patients with primary dengue infections had dengue isolates in Kamphaeng Phet after September in this DF, but 49% of patients with secondary dengue infections had study.
DHF. All four dengue virus types caused both DF and DHF. No
There was excellent agreement between EIA and HAI for correlation between virus type and disease severity could be diagnosing acute dengue infection. Of the 55 secondary cases, demonstrated (table 3) . While types 2 and 3 were almost twice the rise in IgM to dengue did not meet test criteria for an acute as likely to cause DHF rather than DF in this sample, the dengue infection in 3 (change from 15 to 28 U; 0 to 17 U; and difference was not significantly different (Pearson's x 2 , P Å 5 to 22 U). However, in each of these 3 patients, the rise in .3). In comparing the amount of plasma leakage, judged by the IgG to dengue was dramatic (change from 41 to 143 U; 33 to level of the pleural effusion in a right lateral decubitus chest 310 U; and 10 to 289 U, respectively). HAI titers in all 3 radiograph 1 day after defervescence, there was no difference patients rose to §1:5120, and dengue virus was isolated from among dengue virus serotypes (analysis of variance, P Å .3).
the blood. Thus, all secondary dengue infections had positive Kinetics of viremia. The blood samples of children who serologic test results by both EIA and HAI. The time sequence had serologic evidence of an acute dengue infection were denfor serial specimens to be considered positive for acute secondgue virus -positive in nearly all inoculated mosquitoes early in ary dengue infection is shown in figure 3 . All patients with the illness. As an estimate of the virus titer, the mean percentage secondary dengue infections acquired diagnostic levels of antiof inoculated T. splendens mosquitoes that were positive for virus was calculated. The percentage of inoculated mosquitoes that were positive decreased as fever day 0 approached (figure Table 2 . Dengue virus isolation rate by serologic diagnosis. 1). Viremia correlated highly with temperature (Spearman's correlation coefficient, P õ .001). All blood specimens col- 
NOTE. DHF, dengue hemorrhagic fever; DF, dengue fever.
body by EIA by 1 day following defervescence in serial testing. The relative reactivity of IgM for the dengue virus complex was evaluated by determination of levels of IgM to equivalent If assay results were considered individually without the benefit of previous results (single specimen analysis), the EIA was amounts of tetravalent dengue antigen and JEV antigen. JEV is the only other flavivirus known to infect people in Thaidiagnostic in just 29% (15/51) of patients on fever day 0 and 67% (28/42) on fever day 1 (in a single specimen, IgM antiland. EIA identified each of the 60 flavivirus infections as dengue rather than JEV. With 1 exception, the ratio of dengue body against dengue must be §40 U). Diagnostic serology by HAI (79% positive on fever day 1) lagged behind that by IgM to JEV IgM in the follow-up specimen (n Å 49) was ú1, ranging from 1.3 to 22 (mean, 4.8), supporting a serologic EIA. This is because a diagnosis of secondary dengue infection based on HAI antibody responses requires a rising titer diagnosis of dengue rather than Japanese encephalitis (JE). This ratio for the remaining patient was 0.93 on fever day 4, although to ú1:1280. None of 4 cases of primary dengue infections acquired diagnostic levels of dengue antibody by fever day it had been 1.3 on the day of defervescence (fever day 0) and even higher earlier in the illness (4.3, 2.6, and 2.9 on fever 1. IgM antibody, as measured by EIA, developed later in primary infections, and for a diagnosis by HAI, a specimen days 03, 02, and 01, respectively). The ratio of dengue IgM to JEV IgM was most useful to distinguish dengue from JE must be obtained at least 1 week into the illness with a maximum titer of £1:1280.
from fever day 0 onward (figure 4). Levels of IgG against / 9d2f$$au18 06-24-97 11:06:33 jinfas UC: J Infect Figure 3 . % of 55 patients with acute secondary dengue infections acquiring diagnostic levels of dengue antibody by fever day and assay. Plasma was collected daily through fever day 1 and again on study day 8 per study protocol (here grouped as fever day 6). All 4 children with primary dengue infections acquired dengue antibody levels consistent with acute dengue infection after fever day 1 and are not included in this figure. Fever day 0 Å day that temperature dropped to õ38ЊC. EIA measured IgM and IgG antibody against dengue viruses. HAI Å hemagglutination-inhibition antibody assay against 4 serotypes of dengue virus.
illness). However, IgM antibody was elevated on fever day 6 and HAI antibody was present in the follow-up specimens at 6 and 12 months, which had highest antibody titers against the infecting serotype of virus. The timing of the antibody increases early in secondary dengue infections is shown in figure 1 . The HAI antibody titer increased before the antibodies measured by EIA. The IgG ) ; B, secondary dengue (study no. KPP94-007, DEN-2 virus was isolated); and C, recent secondary dengue infection (CHD94-101, no virus isolated). First fever day shown is first day of illness. Fever day 0 is day of defervescence. / Å days on which virus was isolated. HAI Å hemagglutination-inhibition antibody assay. dengue and JEV were similar (r Å .94); therefore, they failed to distinguish between infection with dengue viruses and JEV.
The HAI antibody responses to homologous and heterologous dengue virus antigens were similar. The HAI antibody responses to JEV antigen commonly lagged behind the response to dengue antigens (figure 2B). Among the four primary antibody was not seen on fever day 6 (9 days after onset of / 9d2f$$au18 06-24-97 11:06:33 jinfas UC: J Infect antibodies as measured by EIA increased before IgM and rose able viremia (with the exception of 1 child who was evaluated õ3 h prior to defervescence). Our data demonstrate the occurto higher peak levels.
Virus-antibody interactions. As antibodies increased, the rence of viremia early in the febrile period of dengue and its rapid elimination as fever abates and antibody levels rise. virus titer, as estimated by the percentage of mosquitoes positive for dengue virus, decreased (figure 1). The first day in Ashburn and Craig [20] working in Manila in 1906 first demonstrated that patients with dengue infections were viremic which virus isolation was not possible was identified in 46 patients with secondary dengue infections. For the remainder, early in their illness. Subsequently, virus isolation was confirmed to be more likely early in the illness [21]. Kuberski et a dengue virus was isolated on the last day that blood was obtained during the acute illness. On the last day a virus was al.
[22] isolated dengue virus type 1 in 73% of patients on the first day of illness, with decreasing rates until no isolations isolated, the mean level of IgM antibody against dengue virus was 19 U (range, 0 -123) and the geometric mean HAI antibody were made after 6 days of illness. Higher isolation rates, from 51% to 100%, have also been reported for patients experiencing titer (average of all four dengue types) was 1:140 (range, õ1:10 -1:2560). On the first day a virus was not isolated, the first or primary dengue infections [23, 24] . After the first day of illness, Kuberski et al.
[22] was more likely to isolate virus mean level of IgM against dengue virus was 46 U (range, 2 -160), and the geometric mean HAI titer was 1:860 (range, and demonstrate higher virus titers in children experiencing primary dengue infections. While Gubler et al. [24] also noted 1:24 -1:7240).
Long-term antibody responses. The long-term IgG, IgM, that virus isolation was more common in primary dengue infections, they found that among dengue type 3 infections, the titer and HAI titers for the 55 secondary dengue patients are shown in figure 5 , with data at fever days 03, 6 (during the second of type 3 virus was 5-fold higher in secondary infections. Our data confirm and extend previous data on the relative week of illness), 180, and 365. Dengue IgM antibodies fell to low levels by 6 months (mean, 9 U; range, 0 -40). All children ease of virus isolation early in the illness. Our study has several features that probably explain the high rate of viremia with secondary dengue infections had intermediate HAI antibody levels at 6 months (mean titer, 1:174; n Å 48) and at 12 we found compared with most published studies of DF and DHF [23 -27] . We followed children with fever and obtained months (mean titer, 1:82; n Å 48). The 4 children with primary dengue infections had lower levels of HAI antibody at 6 months serial blood samples from the same patient during the course of illness. Furthermore, children were enrolled in the study (mean titer, 1:17) and 12 months (mean titer, 1:18).
shortly after the onset of illness, during the febrile phase when virus isolation is more likely. On the other hand, Gubler et al. [28] isolated dengue type 2 virus from only 6 of 18 patients Discussion on the island of Tongatapu in 1974 despite specimen collecIn this study of children with acute fever, all children who tion early in the illness. In that study in the Kingdom of Tonga had a dengue virus isolated from their blood had antibody and another study by the same group in central Java in 1978, responses consistent with an acute dengue virus infection, and specimens were collected (live Aedes aegypti mosquitoes fed all children with an acute dengue antibody response had detecton patients) during the first days of illness over several days, yet the isolation rate was only 33% [28, 29] . The illnesses in both the 1974 and 1978 outbreaks ''were remarkable for their mildness and relative short duration''; the lower isolation rate may represent either a difference in virus isolation technique or the presence of a less virulent strain of dengue type 2 virus, resulting in lower virus titer and mild disease. Partial genome sequencing of the 1974 Tonga dengue type 2 virus has shown it to be significantly different from Thai isolates including isolates from our study [30, 31] (Rico-Hesse R, personal communication).
The typical duration of viremia in our patients was 4 -5 days, as has been seen previously [32] . While not statistically significant, our data are consistent with the findings of Kuberski et al. [22] and Gubler et al. [32] in showing that viremia persists longer in children experiencing primary infections rather than secondary dengue infections. Our results suggest that this may Some observers have found that certain serotypes of dengue setting, patients often present later in the course of their illness, and a single high-titered specimen can be assigned a virus (serotypes 2 and 3) are more likely to cause severe disease [23, 29, 33] . However, Gubler et al. [24] could not statistical probability of being associated with an acute secondary dengue infection. In addition, the consistent timing of demonstrate a relationship between dengue serotype and disease severity in Indonesia. In these and other earlier studies, fever, viremia, and antibody responses seen in the present study as well as the other clinical indicators of dengue illness a possible confounder arises from the generally low isolation rates of 15% -65% [23 -27] . If, for example, dengue type 2 [12] document that the children experienced acute illnesses due to dengue virus infection rather than illness due to another virus is easier to recover than the other serotypes of dengue virus, then more severe disease would be falsely biased toward etiology with incidental dengue virus infection. Concerning laboratory diagnosis of acute dengue virus infecdengue type 2.
In the present study, all four dengue virus serotypes were tion, the message of this study is that if the patient with dengue has fever, then attempts at virus isolation (or dengue antigen isolated during a single season in an urban children's hospital and a rural provincial general hospital. The circulation of three detection or genome identification) should be successful while serologic assays may still be negative; conversely, if fever has or more serotypes of dengue throughout Thailand has been observed consistently for 2 decades. This promotes the occurabated, then virus isolation is less likely to be successful and serology is more likely to be diagnostic. rence of sequential dengue infections and appears to sustain endemic DHF. The isolation of virus from nearly 100% of Previous studies of dengue HAI antibody duration following natural infection have been performed as cross-sectional antipatients removes one potential bias in evaluating differences in disease outcomes by infecting dengue serotype. While patients body surveys in areas where clinical dengue has been absent for some time. These studies suggest that HAI antibody against infected with serotypes 2 and 3 were nearly twice as likely to progress from DF (undifferentiated febrile illness) to DHF in dengue virus can be long-lived: Theiler et al. [39] and Rosen [40] found HAI antibody against dengue virus 30 and 45 years, our study, this difference was not statistically significant. Continued enrollment in this study may allow adequate numbers respectively, after the dengue outbreaks of 1927 and 1928 in Greece; Rosen [41] also found HAI antibody 12 years after an of patients to provide a more definitive answer.
Studies of antibody responses in dengue began in 1930 with epidemic in Panama; and Hammon et al. [42] found HAI antibody against dengue type 2 24 years after a dengue epidemic the development of a complement fixation test [34] . The use of HAI antibody assays against all four dengue virus serotypes in 1934 in Florida. The previous studies assumed the HAI antibodies were due to dengue virus infection because the epiin the early 1960s demonstrated that HAI antibody responses were often cross-reacting among the four. The results of HAI demic was clearly dengue on the basis of clinical criteria, and persons born since the epidemic did not have antibody. HAI assays were used to distinguish between primary and secondary dengue infections [35 -37] . More recent studies of antibody antibody has also been shown to be long-lived in persons who were experimentally infected with dengue viruses by allowing kinetics show that, in primary infections, IgM to dengue viruses increases to high levels in nearly all patients within 2 days infected mosquitoes to feed on them. Halstead [43] demonstrated HAI antibody 42 -48 years following experimental denof defervescence and peaks within 2 weeks. In nonprimary (secondary, tertiary, etc.) infections, the IgM response is varigue infections in volunteers infected in the Philippines between 1924 [44] and 1930 [34] . The present study followed HAI able, sometimes absent or lagging behind a dramatic increase in IgG antibodies [18, 38] .
antibody levels in a prospective fashion to 1 year after infection and showed a slow decline in antibody titer between 6 and 12 In the present study, both EIA and HAI antibody results were efficient in the diagnosis of acute dengue virus infections months. We plan to follow children in this study yearly for at least 3 years after infection to further define long-term HAI and were able to identify the infection as primary or secondary. In Southeast Asia, EIA had the further advantage of being antibody responses to dengue viruses. All 4 children experiencing primary dengue infections were able to distinguish dengue from JEV infections. Four patients (2%) not included in the analysis had serologic evidence of classified as having DF compared with secondary patients, of whom 50% demonstrated clear evidence of plasma leakage. a recent rather than an acute dengue infection, that is, a fixed HAI titer of §2560 [13] or EIA antibody levels that were These results are consistent with prior epidemiologic studies of severe dengue illness in secondary cases. In this prospective high and level or falling within 72 h of the onset of illness (e.g., figure 2C ). Given that 90% of dengue infections in Thai study, we demonstrated viremia in 98% of patients early in the course of disease. Further studies will be needed to validate children are mild or asymptomatic [6] , these children probably experienced an asymptomatic dengue infection or mild denmajor tenets of the immune enhancement theory, that is, the effects of preexisting cross-reactive antibody and T cell regue illness prior to the febrile illness that brought them to the hospital. These patients illustrate the difficulties in interpresponses at the time of the secondary infection and the impor-/ 9d2f$$au18 06-24-97 11:06:33 jinfas UC: J Infect
